Visible cracks, crumbling paint and spreading black mold now mar the historic walls of the Duke of York’s 30-room mansion. The Royal Lodge, on 98 acres in Windsor Great Park, has been in royal ...

After Aiden Clark was killed in a school bus accident in Springfield, Ohio, his death inspired conspiracy theories, campaign ...

An extravagant lakefront mansion created by architect Jack Sigrist and interior designer Chris Leighton is on the market in Canandaigua. This 10,560-square-foot home at 4505 Davidsons Landing ...

Farabaugh had watched in dismay as the Central players had collected their district gold medals on the Mansion Park turf the ...

Shares of Eli Lilly and Co. slumped toward their biggest selloff in more than three years on Wednesday, after the drugmaker reported third-quarter results that missed expectations, due to big ...

Eli Lilly has seen tremendous growth from its new GLP-1 drugs, which people have been using for weight loss. Sales growth should continue as the company increases production and looks to win ...

Sales of GLP-1 drugs Mounjaro and Zepbound disappointed investors. (Shelby Knowles/Bloomberg News) Eli Lilly had a bad quarter, with sales of GLP-1 drugs Mounjaro and Zepbound missing analyst ...

It’s time for some Eli Lilly ads and men trying to impress ... how she’s going to survive the rest of the season. At the mansion, Pascal, a 69-year-old man, is finally learning to do his ...

“We’re excited for the challenge to be at Mansion Park again.” Penn Cambria lost each of ... Senior Trent Adams (813, 13 TDs) ...

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.

Also Read: Eli Lilly’s Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron’s Dupixent In the LUCENT-3 trial, mirikizumab helped patients ...